Skip to content

Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study

Observational Study for Identification of Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study (LE-Heart)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00497887
Acronym
LE-Heart
Enrollment
4000
Registered
2007-07-09
Start date
2006-12-31
Completion date
Unknown
Last updated
2010-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Biological Markers, Carotid Artery Diseases, Coronary Arteriosclerosis, Genetic Predisposition to Disease

Brief summary

Atherosclerotic cardiovascular disease is the major cause of morbidity and mortality in Western societies. It is a complex genetic disorder with many genes involved and significant gene-environment interactions. The aim of the study is to identify novel genetic- and biological-markers of atherosclerosis. Atherosclerosis is assessed in the coronary arteries using coronary angiography as well as in the carotid artery (intima-media-thickness) and peripheral vessels (ankle brachial index). Association analysis of genetic and metabolic markers with atherosclerotic burden will be performed to identify novel factors of disposition to atherosclerotic vascular disease.

Interventions

None listed

Sponsors

University of Leipzig
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients assigned to coronary angiography

Exclusion criteria

* Cancer * Acute myocardial infarction * Inability to give informed consent

Countries

Germany

Contacts

Primary ContactJoachim Thiery, MD PhD
thiery@medizin.uni-leipzig.de+49-341-9722201
Backup ContactGerhard Schuler, MD PhD
schug@medizin.uni-leipzig.de+49-341-8650

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 31, 2026